Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

Treats Adults

Francesco Franchi, MD

Cardiologist

Cardiologist

Additional languages:
Italian
Photo of Francesco Franchi

Research at a glance

Top areas of exploration

  • Platelet Aggregation Inhibitors , 78 publications
  • Percutaneous Coronary Intervention , 46 publications
  • Purinergic P2Y Receptor Antagonists , 41 publications
  • Clopidogrel , 34 publications

Research activity

126 publications

3,409 citations

Why is this important?

Active clinical trials

EVOLVE-MI
Investigator
Francesco Franchi
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

126 publications

2024

Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD

JACC: Basic to Translational Science

Publisher's site

2024

Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score

Journal of the American College of Cardiology

PubMed Publisher's site

2024

P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study

JACC: Cardiovascular Interventions

Publisher's site

2024

Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.

Thrombosis and haemostasis

PubMed Publisher's site

2024

The Lipid-Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet Reactivity.

Thrombosis and haemostasis

PubMed Publisher's site